Evaluation of Empiric Antibiotic Therapy Toward Clinical Outcome in Children Patients with Bacterial Meningitis in Dr. Sardjito General Hospital Yogyakarta 2010-2015

https://doi.org/10.22146/farmaseutik.v14i2.42594

Wihda Yanuar(1), Ika Puspita Sari(2*), Titik Nuryastuti(3)

(1) Magister Farmasi Klinik, Fakultas Farmasi, UGM
(2) Departemen Farmakologi & Farmasi Klinik, Fakultas Farmasi, UGM
(3) Departemen Mikrobiologi, Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan, UGM
(*) Corresponding Author

Abstract


Cases of bacterial meningitis in Indonesia reach 158/100,000. Bacterial meningitis attacks children less than 2 years old. Patients with bacterial meningitis who survive are at risk for complications such as brain damage. Therefore, patients with bacterial meningitis, especially in children, need to get optimal therapy. This study aims to determine the pattern of empirical antibiotic use on clinical outcome of pediatric patients with bacterial meningitis in the inpatient ward of Sardjito General Hospital. The study was conducted in an observational descriptive design by collecting data retrospectively on the medical records of patients who met the inclusion criteria. There were 25 patients who met the inclusion criteria. The results showed that 26% use of empiric antibiotics was in accordance with the guidelines for the treatment of bacterial meningitis. Empiric therapy increased clinical outcomes of 40% patients.


Keywords


empiric therapy, clinical outcome, bacterial meningitis

Full Text:

PDF


References

Alam, A., 2011. Kejadian Meningitis Bakterial pada Anak usia 6-18 bulan yang Menderita Kejang Demam Pertama. Fakultas Kedokteran Universitas Padjajaran. Sari Pediatri, 13(4): 293-298.

Brouwer, M.C., Tunkel, A.R., dan van de Beek, D., 2010. Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis. Clinical Microbiology Reviews, 23: 467 492.

El Bashir, H., Laundy, M., dan Booy, R., 2003. Diagnosis and treatment of bacterial meningitis. Archives of disease in childhood, 88: 615–620.

Fiore, A.E., Moroney, J.F., Farley, M.M., Harrison, L.H., Patterson, J.E., Jorgensen, J.H., dkk., 2000. Clinical Outcomes of Meningitis Caused by Streptococcus pneumoniae in the Era of Antibiotic Resistance. Clinical Infectious Diseases, 30: 71–77.

Goldman, J.A. dan Kearns, G.L., 2011. Fluoroquinolone Use in Paediatrics: Focus on Safety and Place in Therapy. World Health Organization, Geneva, Switzerland.

Mengistu, A., Gaeseb, J., Uaaka, G., Ndjavera, C., Kambyambya, K., Indongo, L., dkk., 2013. Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis. J Pharm Policy Pract, 6:.

Prasad, K., Kumar, A., Singhal, T., dan Gupta, P.K., 2007. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis, dalam: The Cochrane Collaboration (Editor), Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK.

Tunkel, A.R., Hartman, B.J., Kaplan, S.L., Kaufman, B.A., Roos, K.L., Scheld, W.M., dkk., 2004. Practice guidelines for the management of bacterial meningitis. Clinical infectious diseases, 39: 1267–1284.



DOI: https://doi.org/10.22146/farmaseutik.v14i2.42594

Article Metrics

Abstract views : 7210 | views : 17106

Refbacks

  • There are currently no refbacks.


Majalah Farmaseutik Indexed by:

   
 
Creative Commons Licence
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.